Method validation.
Altria
K D
KD
Glaxo Research and Development, Ware, Hertfordshire, UK.
D000317:Adrenergic alpha-Antagonists / Q000302:isolation & purification; D002197:Capillary Action; D004586:Electrophoresis / Q000379:methods*; D010883:Piperoxan / Q000031:analogs & derivatives / Q000302:isolation & purification; D011758:Pyrroles / Q000302:isolation & purification; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013237:Stereoisomerism
D000317:Adrenergic alpha-Antagonists; D011758:Pyrroles; D010883:Piperoxan; C065161:fluparoxan